These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations. Devaney K; Vinh TN; Sweet DE Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935 [TBL] [Abstract][Full Text] [Related]
4. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging. Vormoor B; Knizia HK; Batey MA; Almeida GS; Wilson I; Dildey P; Sharma A; Blair H; Hide IG; Heidenreich O; Vormoor J; Maxwell RJ; Bacon CM PLoS One; 2014; 9(1):e85128. PubMed ID: 24409320 [TBL] [Abstract][Full Text] [Related]
5. Primary skeletal neoplasms: osteosarcoma and ewing sarcoma. Hoffer FA Top Magn Reson Imaging; 2002 Aug; 13(4):231-9. PubMed ID: 12409691 [TBL] [Abstract][Full Text] [Related]
6. Increased confidence of diagnosis of Ewing sarcoma using T2-weighted MR images. Hanna SL; Fletcher BD; Kaste SC; Fairclough DL; Parham DM Magn Reson Imaging; 1994; 12(4):559-68. PubMed ID: 8057760 [TBL] [Abstract][Full Text] [Related]
7. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma. Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064 [TBL] [Abstract][Full Text] [Related]
8. MRI of aggressive bone lesions of childhood. Vade A; Eissenstadt R; Schaff HB Magn Reson Imaging; 1992; 10(1):89-96. PubMed ID: 1545687 [TBL] [Abstract][Full Text] [Related]
9. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Machado I; Navarro S; Picci P; Llombart-Bosch A Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835 [TBL] [Abstract][Full Text] [Related]
10. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Shapeero LG; Henry-Amar M; Vanel D Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523 [No Abstract] [Full Text] [Related]
11. The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma. Barnett JR; Gikas P; Gerrand C; Briggs TW; Saifuddin A Skeletal Radiol; 2020 Jun; 49(6):913-919. PubMed ID: 31900513 [TBL] [Abstract][Full Text] [Related]
12. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. Widhe B; Widhe T J Bone Joint Surg Am; 2000 May; 82(5):667-74. PubMed ID: 10819277 [TBL] [Abstract][Full Text] [Related]
13. [The MRT criteria for the differentiation of "pseudotumorous" lesions from bone sarcomas of the extremities]. Lehner K; Rechl H; Daschner H; Kutschker C Rofo; 1993 May; 158(5):416-22. PubMed ID: 8490149 [TBL] [Abstract][Full Text] [Related]
15. Imaging characteristics of primary cranial Ewing sarcoma. Li WY; Brock P; Saunders DE Pediatr Radiol; 2005 Jun; 35(6):612-8. PubMed ID: 15815902 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of osteosarcoma in a patient previously treated for Ewing sarcoma. Hoshi M; Ieguchi M; Yamato K; Tokimasa S; Nakamura H Skeletal Radiol; 2014 Sep; 43(9):1319-24. PubMed ID: 24722657 [TBL] [Abstract][Full Text] [Related]